| Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer SP Fortis, M Sofopoulos, NN Sotiriadou, C Haritos, CK Vaxevanis, ... Journal for immunotherapy of cancer 5, 1-12, 2017 | 82 | 2017 |
| A clinical and biological perspective of human myeloid-derived suppressor cells in cancer C Shipp, L Speigl, N Janssen, A Martens, G Pawelec Cellular and molecular life sciences 73, 4043-4061, 2016 | 74 | 2016 |
| Peripheral blood T-cell signatures from high-resolution immune phenotyping of γδ and αβ T-cells in younger and older subjects in the Berlin Aging Study II K Wistuba-Hamprecht, K Haehnel, N Janssen, I Demuth, G Pawelec Immunity & Ageing 12 (1), 1-12, 2015 | 41 | 2015 |
| SFPQ depletion is synthetically lethal with BRAFV600E in colorectal cancer cells K Klotz-Noack, B Klinger, M Rivera, N Bublitz, F Uhlitz, P Riemer, ... Cell reports 32 (12), 2020 | 38 | 2020 |
| Metabolic drug response phenotyping in colorectal cancer organoids by LC-QTOF-MS SK Neef, N Janssen, S Winter, SK Wallisch, U Hofmann, MH Dahlke, ... Metabolites 10 (12), 494, 2020 | 25 | 2020 |
| CD14+ HLA-DR−/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation L Speigl, H Burow, JK Bailur, N Janssen, CB Walter, G Pawelec, C Shipp Breast Cancer Research and Treatment 168, 401-411, 2018 | 22 | 2018 |
| Raman imaging and fluorescence lifetime imaging microscopy for diagnosis of cancer state and metabolic monitoring L Becker, N Janssen, SL Layland, TE Mürdter, AT Nies, ... Cancers 13 (22), 5682, 2021 | 21 | 2021 |
| Responses of dendritic cells to TLR-4 stimulation are maintained in the elderly and resist the effects of CMV infection seen in the young N Janssen, E Derhovanessian, I Demuth, F Arnaout, ... Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2016 | 18 | 2016 |
| Cytomegalovirus infection minimally affects the frequencies of B-cell phenotypes in peripheral blood of younger and older adults D Goldeck, L Oettinger, N Janssen, I Demuth, E Steinhagen-Thiessen, ... Gerontology 62 (3), 323-329, 2016 | 16 | 2016 |
| Triple targeting of HER receptors overcomes heregulin-mediated resistance to EGFR blockade in colorectal cancer A Rau, N Janssen, L Kühl, T Sell, S Kalmykova, TE Mürdter, MH Dahlke, ... Molecular Cancer Therapeutics 21 (5), 799-809, 2022 | 14 | 2022 |
| Inhibiting HSP90 prevents the induction of myeloid-derived suppressor cells by melanoma cells N Janssen, L Speigl, G Pawelec, H Niessner, C Shipp Cellular Immunology 327, 68-76, 2018 | 12 | 2018 |
| A human ex vivo coculture model to investigate peritoneal metastasis and innovative treatment options D Mönch, J Koch, A Maaß, N Janssen, T Mürdter, P Renner, ... Pleura and Peritoneum 6 (3), 121-129, 2021 | 11 | 2021 |
| Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma L Speigl, N Janssen, B Weide, G Pawelec, C Shipp British Journal of Dermatology 177 (5), 1447-1449, 2017 | 9 | 2017 |
| Peripheral T cell responses to tumour antigens are associated with molecular, immunogenetic and cellular features of breast cancer patients N Janssen, SP Fortis, L Speigl, C Haritos, NN Sotiriadou, M Sofopoulos, ... Breast cancer research and treatment 161, 51-62, 2017 | 7 | 2017 |
| Low levels of intra-tumoural T cells in breast cancer identify clinically frail patients with shorter disease-specific survival L Speigl, A Grieb, N Janssen, S Hatse, B Brouwers, A Smeets, G Floris, ... Journal of geriatric oncology 9 (6), 606-612, 2018 | 6 | 2018 |
| Protocol for establishing a coculture with fibroblasts and colorectal cancer organoids S Wallisch, SK Neef, L Denzinger, D Mönch, J Koch, J Marzi, T Mürdter, ... STAR protocols 4 (3), 102481, 2023 | 3 | 2023 |
| Putative Cancer Stem Cell Markers are Frequently Expressed by Melanoma Cells in Vitro and in Situ but are also Present in Benign Differentiated Cells L Speigl, N Janssen, B Weide, T Sinnberg, G Pawelec, C Shipp Frontiers in Bioscience-Landmark 28 (9), 193, 2023 | 3 | 2023 |
| Predicting clinical outcome in melanoma and breast cancer using blood and tumour-based immune biomarkers: a means to monitor anti-cancer immune responses N Janssen Universität Tübingen, 2020 | 1 | 2020 |
| LABEL-FREE RAMAN MICROSCOPY-BASED MONITORING OF ANTI-CANCER DRUG EFFECTS IN COLORECTAL CANCER ORGANOIDS TOWARDS PATIENT-INDIVIDUALIZED OPTIMIZATION OF TREATMENTS. L Becker, J Marzi, DC Berrio, TE Muerdter, P Renner, MH Dahlke, AT Nies, ... TISSUE ENGINEERING PART A 28, S71-S71, 2022 | | 2022 |
| Patient-derived colonic organoids as a model to study pharmacogenetics N Janssen, A Rau, M Morkel, C Sers, P Renner, T Leibold, M Dahlke, ... NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 392, S54-S54, 2019 | | 2019 |
